{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:47:18Z","timestamp":1756460838036},"reference-count":23,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1507\/endocrj.k09e-172","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T06:01:31Z","timestamp":1261461691000},"page":"1095-1101","source":"Crossref","is-referenced-by-count":11,"title":["Investigation into the Efficacy and Safety of Octreotide LAR in Japanese Patients with Acromegaly: Shizuoka Study"],"prefix":"10.1507","volume":"56","author":[{"given":"Yutaka","family":"OKI","sequence":"first","affiliation":[{"name":"Second Division, Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhide","family":"INOUE","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology Center, Shizuoka General Hospital, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"IMURA","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Yaizu City Hospital, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokutaro","family":"TANAKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Seirei Hamamatsu General Hospital, Hamamatsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieko","family":"GENMA","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"IWABUCHI","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Seirei Mikatahara General Hospital, Hamamatsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"HATAYA","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shizuoka Hospital, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"MATSUZAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Seirei Numazu Hospital, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"IINO","sequence":"additional","affiliation":[{"name":"Second Division, Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"NISHIZAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"NAKAMURA","sequence":"additional","affiliation":[{"name":"Second Division, Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra062453"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031199"},{"key":"3","unstructured":"3. Murray RD, Melmed S (2008) A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. <I>J Clin Endocrinol Metab <\/I>93: 2957-2968."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Vallette S, Serri O (2008) Octreotide LAR for the treatment of acromegaly. <I>Expert Opin Drug Metab Toxicol <\/I>4: 783-793.","DOI":"10.1517\/17425255.4.6.783"},{"key":"5","unstructured":"5. Shimatsu A, Chihara K, Hizuka N, Teramoto A, Tanaka T, Tatsumi K, Tachibana K, Katsumata N, Yokoya S, Fujieda K (2007) Reference intervals of serum insulin-like growth factor-I in adult Japanese population: calculated with LMS methods. <I>Horumon To Rinsho (Clinical endocrinology) <\/I>55: 393-399 (in Japanese)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chanson P, Salenave S (2008) Acromegaly. <I>Orphanet J Rare Dis <\/I>3: 17.","DOI":"10.1186\/1750-1172-3-17"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. <I>Clin Endocrinol (Oxf) <\/I>69: 432-435.","DOI":"10.1111\/j.1365-2265.2008.03221.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. <I>J Clin Endocrinol Metab <\/I>91: 4769-4775.","DOI":"10.1210\/jc.2006-1668"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1191"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-011841"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jackson SN, Fowler J, Howlett TA (1997) Cabergoline treatment of acromegaly: a preliminary dose finding study. <I>Clin Endocrinol (Oxf) <\/I>46: 745-749.","DOI":"10.1046\/j.1365-2265.1997.2491023.x"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004203421604"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (1998) Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. <I>J Neurosurg <\/I>88:1002-1008.","DOI":"10.3171\/jns.1998.88.6.1002"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.53.125"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Colao A, Pivonello R, Auriemma RS, Galdiero M, Savastano S, Lombardi G (2007) Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly. <I>Eur J Endocrinol <\/I>157: 579-587.","DOI":"10.1530\/EJE-07-0383"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ayuk J, Sheppard MC (2008) Does acromegaly enhance mortality? <I>Rev Endocr Metab Disord <\/I>9: 33-39.","DOI":"10.1007\/s11154-007-9067-8"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02825.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Colao A, Marek J, Goth MI, Caron P, Kuhn JM, Minuto FM, Weissman NJ (2008) No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly. <I>J Clin Endocrinol Metab <\/I>93: 2243-2248.","DOI":"10.1210\/jc.2007-2199"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.51.227"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Colao A, Auriemma RS, Galdiero M, Cappabianca P, Cavallo LM, Esposito F, Grasso LF, Lombardi G, Pivonello R (2009) Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. <I>J Clin Endocrinol Metab <\/I>94: 528-537.","DOI":"10.1210\/jc.2008-1546"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1159\/000095535"},{"issue":"6","key":"22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1507\/endocrj1954.33.743","volume":"33","author":"HORIKAWA R","year":"1986","ISSN":"http:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.42.739"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/56\/9\/56_K09E-172\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:52:03Z","timestamp":1618296723000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/56\/9\/56_K09E-172\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k09e-172","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}